XML 42 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Taxes on Income (Tables)
12 Months Ended
Dec. 31, 2017
Income Tax Disclosure [Abstract]  
Schedule of Components of Loss Before Income Taxes

The components of loss before income taxes are as follows:

 

    Year ended  December 31  
    2017     2016  
    ($ in thousands)
Loss before taxes on income:                
InspireMD, Inc.   $ (3,673 )   $ (3,640 )
Subsidiaries     (4,738 )     (4,820 )
    $ (8,411 )   $ (8,460 )

Schedule of Changes in Valuation Allowance

The changes in the valuation allowance for the year ended December 31, 2017 and 2016 were as follows:

 

    Year ended December 31  
    2017     2016  
    ($ in thousands)  
Balance at the beginning of the year   $ 29,682     $ 28,970  
Changes during the year:                
Changes following enactment of the Act     (5,879 )        
Other changes     3,437       712  
Balance at the end of the year   $ 27,240     $ 29,682  

Schedule of Reconciliation of Uncertain Tax Positions

Following is a reconciliation of the total amounts of the Company’s uncertain tax positions during the year ended December 31, 2017:

 

    Year ended December 31, 2017  
      ($ in thousands)  
Balance at beginning of period   $ -  
Increase in uncertain tax positions because of tax positions taken during the year     28  
Balance at end of period   $ 28  

Schedule of Open Tax Years by Major Jurisdiction

A summary of open tax years by major jurisdiction is presented below:

 

Jurisdiction

Years

U.S. 2014-2017
Israel 2013-2017
Germany 2012-2017
United Kingdom 2014-2015

Schedule of Deferred Income Tax

    December 31,  
    2017     2016  
    ($ in thousands)  
       
Short-term*:                
Allowance for doubtful accounts   $ -     $ 64  
Allowance for bonus                
Provision for vacation and recreation pay             34  
      -       98  
Long-term*:                
Allowance for doubtful accounts     3          
Allowance for bonus     54          
Provision for vacation and recreation pay     37          
R&D expenses     289       459  
Share-based compensation     2,577       4,027  
Carry forward tax losses     24,245       25,053  
Accrued severance pay, net     35       45  
      27,240       29,584  
Less-valuation allowance     (27,240 )     (29,682 )
    $ -     $ -  

 

* 2017 balances are presented under long term deferred taxes, due to implementation of ASU 2015-17.